. 2013 Dec 19;2(6):e000399. doi: 10.1161/JAHA.113.000399

Table 3.

Multivariable‐adjusted Association of Statistically Significant Biomarkers With Prevalence of Each Echocardiographic Outcome

	Composite (574/2460)^†	LVH_80 (489/2460)^†	LVSD_MILDGR (142/2460)^†	LVSD_MODSEV (51/2460)^†
BNP	1.29 (1.15 to 1.44)^**	1.25 (1.11 to 1.41)^**	1.43 (1.17 to 1.73)^**	1.79 (1.30 to 2.47)^**
GDF‐15	1.14 (1.004 to 1.28)^*	NS	1.41 (1.16 to 1.70)^**	NS
hsTnI	1.18 (1.06 to 1.31)^*	1.22 (1.09 to 1.36)^**	NS	NS

Values represent odds ratios (95% confidence intervals) per 1 SD increment in log‐biomarker. ST2 was not significantly associated with any outcome. BNP indicates B‐type natriuretic peptide; GDF‐15, growth differentiation factor‐15; hsTnI, high‐sensitivity troponin I; LVH, left ventricular hypertrophy; LVSD, left ventricular systolic dysfunction; LVSD_MILDGR, mild/greater LVSD; LVSD_MODSEV, moderate/severe LVSD; NS, no statistically significant association.

*P<0.05, **P<0.001.

†Number of outcomes/number at risk.